Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia

NCT06802523 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

53

Enrollment

NIH

Sponsor class

Stopped Drug Supply Issues

Conditions

Acute Myeloid Leukemia

Interventions

RADIATION: Actinium Ac 225 Lintuzumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
DRUG: Decitabine and Cedazuridine
DRUG: Venetoclax

Sponsor

National Cancer Institute (NCI)